Expect More Use of the Antibiotics Avycaz or Vabomere for "CRE"

October 2018

You'll hear continued debate about which antibiotics to use to treat carbapenem-resistant Enterobacteriaceae (CRE) infections.

Work with ID to tailor regimens based on susceptibility and safety.

Newer antibiotics. Anticipate using ceftazidime/avibactam (Avycaz) or meropenem/vaborbactam (Vabomere) more. Recent evidence suggests they are safer and may be more effective than traditional options...such as meropenem PLUS a polymyxin (colistin, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote